Mark Levin
InvestorFounderBoard director at Fulcrum Therapeutics · Board director at Corvia Medical · Board director at NinePoint Medical
East Coast
Writes $100K – $5M checks · typically $1.5M
About
Mark Levin co-founded Third Rock Ventures in 2007, joining after more than 30 years of launching and building biotechnology companies. Before Third Rock, he co-founded Millennium Pharmaceuticals in 1993 and served as its chief executive officer; the company was later acquired by Takeda Oncology. At Third Rock, he focused on the formation, development, and strategic governance of the firm's portfolio companies. He met Third Rock co-founders Bob Tepper and Kevin Starr during his time at Millennium.
Invests in
BiotechHealthtechMedical Devices
Beyond investing
- Founded
- Co-founded Third Rock Ventures in 2007. Co-founded Millennium Pharmaceuticals in 1993, later acquired by Takeda Oncology.
- Education
- Earned an M.S. in Chemical Engineering and Biochemical Engineering from Washington University in St. Louis. Earned a B.S. from Washington University in St. Louis.
From Mark's own website — common ground for a warm intro.
Board director at Fulcrum Therapeutics
Intro paths
In turn, Mark can intro founders to Fulcrum Therapeutics's investors below.
Fulcrum Therapeutics's investors · 2
Board director at Corvia Medical
Intro paths
In turn, Mark can intro founders to Corvia Medical's investors below.
Board director at NinePoint Medical
Intro paths
In turn, Mark can intro founders to NinePoint Medical's investors below.
NinePoint Medical's investors · 1
Experience
- The Possible ZoneChairman Of The Board Of Directorscurrent2009 — present31 Heath Street Boston Ma
- third rock venturesPartnercurrent2007 — present
- millenniumCEO, Chairman of Board and Board Member1993 — 2008
- mayfield fundpartner1987 — 1993
- GenentechLeader of Process Engineering and Project leader on multiple R and D Programs1981 — 1987
- FoxboroHead Of Marketing1979 — 1981Foxborough (Foxboro), Massachusetts, United States
- Miller Brewing CompanyStartup Engineer and Production Manager1977 — 1979Eden, North Carolina, United States
- Eli Lilly and CompanyProcess Development Engineer1974 — 1977Indianapolis, Indiana, United States
Education
- Washington University in St. Louisms cheENG, BioChemical engineering1968 — 1974
Deals · 4
Fulcrum TherapeuticsBoard seat
via Third Rock Ventures · filed Jul 2017 · $55M raise
NinePoint MedicalBoard seat
via Third Rock Ventures · filed Nov 2015 · $40.7M raise
Corvia MedicalBoard seat
via Third Rock Ventures · filed Sep 2015 · $34M raise
Voyager Therapeutics, Inc.Board seat
via Third Rock Ventures · filed Apr 2015
Attribution from SEC filings, press coverage, and firm rosters.
Frequently asked questions
- Who is Mark Levin?
- Mark Levin co-founded Third Rock Ventures in 2007, joining after more than 30 years of launching and building biotechnology companies. Before Third Rock, he co-founded Millennium Pharmaceuticals in 1993 and served as its chief executive officer; the company was later acquired by Takeda Oncology. At Third Rock, he focused on the formation, development, and strategic governance of the firm's portfolio companies. He met Third Rock co-founders Bob Tepper and Kevin Starr during his time at Millennium.
- Where does Mark Levin work?
- Mark Levin is Board director at Fulcrum Therapeutics and Board director at Corvia Medical and Board director at NinePoint Medical.
- What does Mark Levin invest in?
- Mark Levin invests in Biotech, Healthtech, Medical Devices.
- What check size does Mark Levin write?
- Mark Levin typically writes checks of $100K – $5M.
- What boards does Mark Levin sit on?
- Mark Levin holds tracked board seats at Corvia Medical, Fulcrum Therapeutics, NinePoint Medical, Voyager Therapeutics, Inc..
- Where did Mark Levin go to school?
- Mark Levin studied at Washington University in St. Louis (ms cheENG, BioChemical engineering).
Same school
Also attended Washington University in St. Louis165
+ 159 more
Shared employers
Also worked at The Possible Zone1
Also worked at mayfield fund35
+ 29 more
Also worked at Genentech95
+ 89 more
Also worked at Eli Lilly and Company79
+ 73 more
























